cas 66346-94-9|| where to buy 6-(4-Methylpiperazin-1-yl)pyridazin-3-amine

Nom du produit:6-(4-Methylpiperazin-1-yl)pyridazin-3-amine

IUPAC Name:6-(4-methylpiperazin-1-yl)pyridazin-3-amine

Unité d'emballage	Stock disponible	Prix($)
CM164032-100mg	in stock	ŭŭ
CM164032-250mg	in stock	Ȁǯƅ
CM164032-1g	in stock	ŔƏŭ
CM164032-5g	in stock	ƻǕň

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 66346-94-9 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:66346-94-9; Formule moléculaire:C9H15N5; Point de fusion:-; Code SMILES:NC1=NN=C(N2CCN(C)CC2)C=C1; Densité:

: Numéro de catalogue:CM164032; Poids moléculaire:193.25; Point d'ébullition:; N° Mdl:MFCD13192341; Stockage:

: Pyridazines; Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.